Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients

Diseases of the Colon and Rectum

Volumn 52, Issue 8, 2009, Pages 1452-1459

  Baek, Yoo Hum ^a   Chang, Eugene ^a   Kim, Young Jin ^a   Kim, Bo Kyoung ^a   Sohn, Jin Hee ^a   Park, Dong Il ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Colorectal neoplasms; Screening; Stool DNA

Indexed keywords

BISULFITE; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER; VIMENTIN;

ADULT; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; COLORECTAL ADENOMA; COLORECTAL TUMOR; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; HUMAN MUT L HOMOLOG 1 GENE; MAJOR CLINICAL STUDY; MALE; METHYLATION; METHYLGUANINE DNA METHYLTRANSFERASE GENE; ONCOGENE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIMENTIN GENE; CHEMISTRY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DNA METHYLATION; FECES; GENETIC EPIGENESIS; GENETICS; KOREA; METABOLISM; METHODOLOGY; MIDDLE AGED; PREVALENCE; PROMOTER REGION; RETROSPECTIVE STUDY; RISK FACTOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DNA METHYLATION; DNA REPAIR ENZYMES; DNA, NEOPLASM; EPIGENESIS, GENETIC; FECES; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; PREVALENCE; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 68149181469     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181a79533     Document Type: Article

References (14)

1. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159070.
2. Grady WM. Epigenetic events in the colorectum and in color cancer. Biochem Soc Trans 2005;33:684-688
3. Pignone M, Rich M, Teutsch SM, et al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 137:132-141 (Pubitemid 34779159)
4. Sindransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102-105
5. Ahlquist DA , Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000; 119:1219.
6. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Fecal DNA vs. fecal occult blood for colorectal-cancer screening in an averagerisk population. N Engl J Med 2004;351:2704-2714
7. Tagore K, Ross M, Shuber A. Stool-based DNA multitarget assay for the detection of colorectal cancer (CRC) and advanced adenomas. Gastroenterology 2002;122:A481.
8. Syngal S , Chung D, Willet C. Stool DNA analysis for the detection and follow-up of colorectal (CRC) and advanced adenomas (AA): sensitivity in a prospective series. AmJ Gastoenterol 2002; 97:S109.
9. Suzuki H, Gabrielson, E , Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002;31:141-149
10. Chen WD , Han ZJ, Skoletsky J, et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005;97:1124-1132
11. Muller HM, Oberwalder M , Fiegl H, et al. Methylation changes in faecal DNA: a marker for colorectal screening? Lancet 2004; 363:1283-1285
12. Lenhard K , Bommer GT, Asutay S, et al. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 2005;3;142-149
13. Petko Z, Ghiassi M, Shuber A, et al. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 2005;11:1203-1209
14. Davies RJ, Miller, R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 2005;5: 199-209.